PLB-1001

• Description :

  PLB-1001 (Bozitinib, PLB1001, CBI-3103, CBT-101) is a potent, highly selective, ATP-competitive, BBB-permeable MET kinase inhibitor, potently inhibits MET activity by 95.1% at 2 uM.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  424.391

• Molecular Formula :

  C20H15F3N8

• Notes :

  Research use only, not for human use.

• Receptor :

  C-Met/HGFR

• CAS Number :

  1440964-89-5